Jacobs Levy Equity Management, Inc Ptc Therapeutics, Inc. Transaction History

Jacobs Levy Equity Management, Inc

$24.2 Billion
Q2 2025

A detailed history of Jacobs Levy Equity Management, Inc transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Jacobs Levy Equity Management, Inc holds 4,542 shares of PTCT stock, worth $205,616. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,542

Previous 36,069 87.41%

Holding current value

$205,616

Previous $1.84 Million 87.98%

% of portfolio

0.0%

Previous 0.01%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$36.19 - $52.13 $1.14 Million - $1.64 Million	-31,527 Reduced 87.41%	4,542 $221,000
Q1 2025 May 15, 2025	SELL	$41.81 - $57.17 $33 Million - $45.2 Million	-790,450 Reduced 95.64%	36,069 $1.84 Million
Q4 2024 Feb 14, 2025	SELL	$34.99 - $52.07 $23.1 Million - $34.4 Million	-659,778 Reduced 44.39%	826,519 $37.3 Million
Q3 2024 Nov 14, 2024	SELL	$30.39 - $37.66 $6.97 Million - $8.64 Million	-229,494 Reduced 13.38%	1,486,297 $55.1 Million
Q2 2024 Aug 14, 2024	BUY	$24.69 - $40.12 $2.71 Million - $4.41 Million	109,950 Added 6.85%	1,715,791 $52.5 Million
Q1 2024 May 15, 2024	BUY	$24.15 - $31.95 $6.82 Million - $9.02 Million	282,422 Added 21.34%	1,605,841 $46.7 Million
Q4 2023 Feb 14, 2024	BUY	$18.07 - $29.37 $3.63 Million - $5.9 Million	200,721 Added 17.88%	1,323,419 $36.5 Million
Q3 2023 Nov 16, 2023	BUY	$22.41 - $41.99 $2.33 Million - $4.37 Million	104,024 Added 10.21%	1,122,698 $25.2 Million
Q2 2023 Aug 14, 2023	BUY	$40.4 - $59.1 $12 Million - $17.5 Million	295,801 Added 40.92%	1,018,674 $41.4 Million
Q1 2023 May 15, 2023	SELL	$38.16 - $48.86 $6.05 Million - $7.74 Million	-158,483 Reduced 17.98%	722,873 $35 Million
Q4 2022 Feb 14, 2023	BUY	$33.53 - $54.79 $11 Million - $18 Million	328,493 Added 59.42%	881,356 $33.6 Million
Q3 2022 Nov 15, 2022	SELL	$41.85 - $53.85 $11.3 Million - $14.5 Million	-269,231 Reduced 32.75%	552,863 $27.8 Million
Q2 2022 Aug 15, 2022	BUY	$25.6 - $45.23 $4.84 Million - $8.55 Million	189,064 Added 29.87%	822,094 $32.9 Million
Q1 2022 May 16, 2022	BUY	$33.33 - $44.6 $1.79 Million - $2.4 Million	53,814 Added 9.29%	633,030 $23.6 Million
Q4 2021 Feb 14, 2022	BUY	$35.36 - $41.86 $5.25 Million - $6.21 Million	148,459 Added 34.46%	579,216 $23.1 Million
Q3 2021 Nov 15, 2021	BUY	$37.01 - $44.74 $95,633 - $115,608	2,584 Added 0.6%	430,757 $16 Million
Q2 2021 Aug 16, 2021	BUY	$37.95 - $49.37 $11 Million - $14.3 Million	290,189 Added 210.31%	428,173 $18.1 Million
Q1 2021 May 17, 2021	BUY	$46.8 - $68.92 $4.31 Million - $6.35 Million	92,099 Added 200.72%	137,984 $6.53 Million
Q4 2020 Feb 16, 2021	SELL	$47.96 - $67.64 $98,797 - $139,338	-2,060 Reduced 4.3%	45,885 $2.8 Million
Q3 2020 Nov 16, 2020	SELL	$45.41 - $57.07 $202,119 - $254,018	-4,451 Reduced 8.49%	47,945 $2.24 Million
Q2 2020 Aug 17, 2020	BUY	$42.56 - $54.98 $1.04 Million - $1.35 Million	24,470 Added 87.62%	52,396 $2.66 Million
Q1 2020 May 15, 2020	BUY	$32.37 - $59.36 $699,709 - $1.28 Million	21,616 Added 342.57%	27,926 $1.25 Million
Q4 2019 Feb 14, 2020	SELL	$32.22 - $50.07 $6,444 - $10,014	-200 Reduced 3.07%	6,310 $303,000
Q3 2019 Nov 14, 2019	BUY	$33.82 - $48.17 $50,730 - $72,255	1,500 Added 29.94%	6,510 $220,000
Q2 2019 Aug 13, 2019	BUY	$35.42 - $45.0 $177,454 - $225,450	5,010 New	5,010 $225,000
Q4 2018 Feb 14, 2019	SELL	$29.83 - $46.51 $380,034 - $592,537	-12,740 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$33.9 - $47.77 $39,324 - $55,413	-1,160 Reduced 8.35%	12,740 $599,000
Q2 2018 Aug 14, 2018	BUY	$25.7 - $47.88 $357,230 - $665,532	13,900 New	13,900 $469,000
Q1 2018 May 15, 2018	SELL	$17.46 - $32.59 $206,901 - $386,191	-11,850 Closed	0 $0
Q4 2017 Feb 13, 2018	BUY	$15.14 - $20.89 $179,409 - $247,546	11,850	11,850 $198,000

Others Institutions Holding PTCT

# of Institutions

307

Shares Held

80.1M

Call Options Held

255K

Put Options Held

141K

View Full List

About PTC THERAPEUTICS, INC.

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $3.24B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

More about PTCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.

Account

Jacobs Levy Equity Management, Inc Ptc Therapeutics, Inc. Transaction History